Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Medical Center Groningen

About this trial

Motive:

In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from lung cancer patients.

Goal:

To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.

A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.

Eligibility criteria

Qualifiers

Patients with NSCLC or SCLC-LD or thymoma or lung metastases (treated with stereotactic radiotherapy)

Patients receiving radiotherapy dose > 40 Gy

Disqualifiers

Failure to comply with any of the inclusion criteria

Trial design

Treatments tested in this trial

  • Radiotherapy

Treatment groups

No treatment groups listed